We use to pay over $100 a month for Zocor. The generic now runs $10 a month (since July 2007).
Drug developer Teva Pharmaceutical Industries Ltd. said Friday a U.S. District Court ordered Teva to tentatively refrain from selling a generic version of Eisai Co.'s Alzheimer's treatment Aricept.
The tentative injunction by the U.S. District Court for the District of New Jersey was requested by Japan's Eisai as part of an ongoing lawsuit with Teva.
Teva has already gained tentative Food and and Drug Administration approval for the generic drug and could receive final approval April 26, when the mandatory stay of approval under the patent lawsuit expires. A trial date has not yet been set.